Related by context. Frequent words. (Click for all words.) 65 Initiate Phase 62 PRECiSE 62 Pivotal Phase 62 placebo controlled Phase 61 Randomized controlled 61 GSK# [001] 61 double blinded placebo 60 Phase Ib clinical 60 Phase IIIb 60 multicenter Phase 59 NSABP 59 multicenter randomized double 59 nab paclitaxel 59 Thrombolysis 59 elotuzumab 59 secondary efficacy endpoints 58 TRITON TIMI 58 Pivotal Phase III 58 APTIVUS 58 Multicenter 58 Pulmonary Arterial Hypertension 58 DDP# 57 substudy 57 Pharmacokinetic 57 nonrandomized 57 Solid Tumors 57 MKC# 57 placebo controlled clinical 57 KRN# 57 RADIANT 57 ACCLAIM 57 TELCYTA 57 pharmacokinetic PK 57 placebo controlled clinical trials 57 CR# vcMMAE 57 pharmacokinetics PK 57 Metastatic Melanoma 56 Acute Myocardial Infarction 56 Phase IIB 56 Phase 1a 56 RESIST 56 Traficet EN 56 registrational trial 56 phase IIb clinical 56 Phase III Clinical Trial 56 μg kg 56 Amrubicin 56 blinded placebo controlled 56 pharmacodynamic effects 56 Meta Analysis 56 ATTAIN 56 prospectively defined 56 Ischemic 56 tanespimycin 56 prospective randomized controlled 55 multicenter randomized 55 phase IIb 55 NYHA Class III 55 placebo controlled randomized 55 Hypoactive Sexual Desire Disorder 55 active comparator 55 Phase 1b trial 55 NHANES III 55 subgroup analyzes 55 Pivotal Trial 55 #mg/day [001] 55 Engerix B 55 phase IIa 55 MIRCERA 55 phase IIa clinical 55 multicentre 55 subanalysis 55 PEG SN# 55 placebo controlled studies 55 pharmacokinetic parameters 55 forodesine 54 randomized Phase III 54 liposomal formulation 54 EndoTAG TM -1 54 Initiates Phase 54 Aliskiren 54 fluvastatin 54 Percutaneous Coronary Intervention 54 composite endpoint 54 vismodegib 54 phase 2a 54 liver transplant recipients 54 Phase III randomized 54 Cloretazine R VNP#M 54 efficacy endpoint 54 Gastric Cancer 54 prospective observational 54 sipuleucel T 54 ascending doses 54 II Clinical Trial 54 RIBBON 54 Diamyd ® 54 EDEMA4 54 Patient Registry 54 NYHA Class II 54 MADIT CRT